Table II.

Demographic and epidemiologic data of the 12 patients.

	GN01T	GN02	GN03	GN04	GN05	GN06	GN07	GN08	GN09	GN10	GN11	GN12
Patient	LI	HZ	PI	PP	PB	ZI	MK	DG	ME	TS	KS	SK
Date of isolation (date/month/year)	16/12/02	19/2/03	14/7/03	22/7/03	2/8/03	8/8/03	8/8/03	13/8/03	21/8/03	8/9/03	10/9/03	31/10/03
Age (years)	74	76	62	83	42	70	–	59	35	82	76	77
Gender	M	M	M	M	M	M	F	M	M	M	M	M
Nationality	H	H	H	H	O	H	H	H	O	H	H	H
Sample	SP	SP	SP	SP	BAL	SP	U	SP	SP	SP	SP	SP
Ward	PN	HEM	PN	GAS	–	PN	–	HEM	PN	ICU	PN	ORTH
Compartment	C	C	C	A	–	C	–	C	C	C	C	B
Prior hospital stay	51	11	17	11	–	2	–	66	4	3	5	5
Underlying disease	D, RF, CHF	MDS	COPD	COPD, AN	TB	CA, COPD	–	NHL	REYM	CHF, PF	CPF	CA, COPD
Death within 3 mo.	N	Y	Y	N	N	N	N	N	N	Y	Y	Y

M, male; F, female; H, Hellenic; O, other; SP, sputum; BAL, broncho-alveolar lavage; U, urine; PN, pneumonology; Hem, hematology; GAS, gastroenterology; ICU, intensive care unit; ORTH, orthopedics; D, diabetes; RF, renal failure; CHF, congestive heart failure; MDS, myelodysplastic syndrome; COPD, chronic obstructive pulmonary disease; AN, anemia; TB, tuberculosis; CA, cancer; NHL, Non-Hodgkin lymphoma; REYM, rheumatologic disease; PF, pulmonary fibrosis; CPF, cardiopulmonary failure; Y, yes; N, no; mo., months.